To check your eligibility for a Roundup settlement, you must meet several core requirements: a diagnosis of non-Hodgkin lymphoma or related cancer after using Roundup, documented exposure of at least 80 hours over two years before diagnosis, a diagnosis date on or after June 1, 2018, and you cannot have already accepted a previous Roundup settlement. For example, a landscaper diagnosed with NHL in 2020 who used Roundup professionally for five years would likely meet the basic eligibility criteria, while someone who used the product once in their backyard and later developed an unrelated condition would not qualify. The eligibility determination process extends beyond these initial requirements.
You will need to gather specific evidence, understand how the point-based settlement system works, and be aware of your state’s statute of limitations. With approximately 61,000 open cases nationwide and Bayer having paid over $11 billion in settlements and verdicts to date, the stakes remain significant for qualifying plaintiffs. This article covers the specific documentation you need, how settlement amounts are calculated through the point system, current deadlines and statutes of limitations, and a major Supreme Court case in 2026 that could fundamentally change the litigation landscape.
Table of Contents
- What Are the Basic Requirements to Qualify for a Roundup Settlement?
- What Evidence Do You Need to Prove Roundup Exposure and Injury?
- How Does the Point-Based Settlement System Calculate Payouts?
- What Is the Current Status of Roundup Litigation in 2026?
- How Could the Supreme Court’s 2026 Review Affect Your Claim?
- What Steps Should You Take to Begin the Eligibility Process?
- What Happens After Filing a Roundup Claim?
- Conclusion
What Are the Basic Requirements to Qualify for a Roundup Settlement?
The foundation of any Roundup claim rests on four interconnected requirements. First, you must have a qualifying medical diagnosis, specifically non-Hodgkin lymphoma or a related cancer that has been linked to glyphosate exposure. Second, you need to demonstrate substantial exposure to Roundup, which courts and settlement administrators generally define as at least 80 hours of use over a two-year period before your diagnosis. This threshold excludes casual users who might have sprayed weeds once or twice. Third, your diagnosis must have occurred on or after June 1, 2018.
Claims involving earlier diagnoses face additional complications and may be subject to different procedural requirements. Fourth, you cannot have already signed a release as part of a previous Roundup settlement. If you accepted a prior settlement offer, even a smaller one, you have likely waived your right to pursue additional compensation. A critical caveat applies to timing: each state has its own statute of limitations for personal injury claims, typically ranging from one to six years from the date of diagnosis, though most states fall within a one-to-three-year window. A plaintiff in California might have two years to file, while someone in Maine might have six. Missing this deadline generally extinguishes your claim entirely, regardless of how strong your evidence might be.
What Evidence Do You Need to Prove Roundup Exposure and Injury?
Building a viable roundup claim requires two categories of proof: evidence of exposure and evidence connecting that exposure to your illness. For exposure documentation, courts accept various forms of evidence including receipts for Roundup purchases, partially used containers of the product, invoices from landscaping work, or proof of employment in an industry where herbicide exposure was common, such as agriculture, groundskeeping, or municipal maintenance work. Medical documentation forms the second pillar. You need records confirming your cancer diagnosis, treatment history, and ideally expert medical testimony establishing a causal link between glyphosate exposure and your specific condition.
This is where many cases become complex. The burden falls on plaintiffs to connect their exposure to their illness through credible medical evidence, not merely to show they used the product and later developed cancer. However, if your primary evidence is circumstantial, such as recollections of using Roundup without receipts or employment records, your case becomes more difficult but not impossible. Some plaintiffs have successfully relied on witness testimony from family members, coworkers, or neighbors who can corroborate regular Roundup use. The key limitation is that vague claims of occasional use typically fail to meet the 80-hour threshold that settlement administrators apply.
How Does the Point-Based Settlement System Calculate Payouts?
Settlement administrators use a scoring system to determine individual payouts, which explains the wide range of settlement amounts, from $5,000 to $250,000. The average payout has been approximately $150,000 to $160,000 per plaintiff, but your specific award depends on several weighted factors. The type and stage of your cancer matters significantly, with more aggressive or advanced cancers receiving higher point values. Other scoring factors include your age at diagnosis, the duration and frequency of your Roundup use, how your illness has affected your ability to work, the intensity of your medical treatment, and whether you are still living.
Wrongful death claims involving plaintiffs who have passed away receive additional consideration. The system also awards bonus points for cases with particularly strong evidence of causation. For instance, a 45-year-old professional landscaper diagnosed with Stage III NHL after 15 years of daily Roundup use who required chemotherapy and can no longer work would score substantially higher than a 70-year-old retiree diagnosed with early-stage lymphoma after occasional residential use. This tiered approach means two plaintiffs with the same diagnosis might receive dramatically different settlements based on their individual circumstances.
What Is the Current Status of Roundup Litigation in 2026?
Bayer has now resolved nearly 100,000 lawsuits and paid over $11 billion in settlements and verdicts. Despite this, approximately 61,000 open cases remain nationwide, with 4,511 consolidated in the federal multidistrict litigation in California. The company has faced roughly 181,000 total Roundup claims, predominantly from residential users rather than agricultural professionals. Bayer added $1.37 billion to its settlement reserves in August 2025 and recently provisioned an additional $1.3 billion. The company has publicly stated its goal to largely resolve the litigation by the end of 2026.
For plaintiffs, this timeline creates both opportunity and pressure. Settlement offers may be more readily available as Bayer works toward resolution, but the window for filing new claims continues to narrow as statutes of limitations expire. Individual jury verdicts have far exceeded typical settlement amounts. Juries have awarded $175 million, $332 million, $2.1 billion, and $2.25 billion in separate cases. These verdicts are often reduced on appeal or during post-trial negotiations, but they demonstrate what plaintiffs can potentially achieve by going to trial rather than accepting settlement offers. The tradeoff is significant: trials involve years of litigation, uncertain outcomes, and substantial legal costs that settlements avoid.
How Could the Supreme Court’s 2026 Review Affect Your Claim?
On January 16, 2026, the U.S. Supreme Court agreed to hear the Durnell case, a development that could fundamentally reshape Roundup litigation. The central question is whether federal pesticide labeling law, specifically the Federal Insecticide, Fungicide, and Rodenticide Act, preempts state-law failure-to-warn claims. A decision is expected during the Court’s current session, ending in June 2026. If the Supreme Court rules in Bayer’s favor, the impact could be severe for pending and potential plaintiffs. A finding of federal preemption could significantly limit or entirely end thousands of lawsuits by eliminating the legal theory underlying most claims.
Plaintiffs have argued that Monsanto, which Bayer acquired in 2018, should have warned consumers about cancer risks. Bayer contends that federal labeling requirements prevent states from imposing additional warning obligations. Potential plaintiffs face a difficult calculation. Filing a claim before the Supreme Court rules preserves your legal options, but a favorable ruling for Bayer could render your claim worthless. Waiting to see how the Court rules risks running out your statute of limitations. There is no clearly correct strategy here, which is why consulting with an attorney familiar with Roundup litigation is particularly important in the current legal environment.
What Steps Should You Take to Begin the Eligibility Process?
The practical path to determining eligibility starts with documenting your exposure history before memories fade and evidence disappears. Write down your recollections of Roundup use, including dates, locations, frequency, and duration. Identify potential witnesses who observed your use of the product. Gather any physical evidence, such as old containers, purchase records, employment records, or photographs showing you using herbicides. Simultaneously, compile your complete medical history related to your cancer diagnosis.
Request records from every healthcare provider involved in your diagnosis and treatment. Note any discussions with doctors about potential causes of your illness. This documentation serves two purposes: establishing the medical foundation of your claim and providing the information attorneys need to evaluate your case. Many law firms handling Roundup cases offer free case evaluations, and most work on contingency, meaning they collect fees only if you receive compensation. This structure makes initial consultations accessible, but be aware that contingency fees typically range from 25% to 40% of any recovery. Comparing multiple firms and understanding their fee structures before signing representation agreements is advisable.
What Happens After Filing a Roundup Claim?
Once you file a claim, the process enters a phase that can take months or years depending on how your case proceeds. Claims may be resolved through negotiated settlements, which tend to move faster, or through trial, which involves extensive discovery, expert testimony, and court proceedings. The nearly 100,000 cases Bayer has already settled demonstrate that most claims resolve without trial.
Looking ahead, the Supreme Court’s pending decision creates significant uncertainty. Regardless of that outcome, plaintiffs with solid documentation and clear evidence of substantial exposure before diagnosis remain in the strongest position. Those whose claims sit closer to the eligibility margins, such as borderline exposure hours or weaker causation evidence, face greater risk from both individual case evaluation and broader legal developments.
Conclusion
Eligibility for a Roundup settlement requires meeting specific criteria: a qualifying cancer diagnosis after June 1, 2018, documented exposure of at least 80 hours over two years, compliance with your state’s statute of limitations, and no prior settlement release. The point-based system means your individual circumstances, including cancer type and stage, age, exposure duration, and treatment intensity, directly determine potential compensation within the typical $5,000 to $250,000 range.
The current litigation landscape combines opportunity and risk. With Bayer targeting resolution by the end of 2026 and the Supreme Court reviewing a case that could dramatically limit plaintiff claims, timing matters. Gathering your documentation, understanding the specific requirements, and consulting with qualified legal counsel sooner rather than later positions you to make informed decisions about whether and how to pursue a claim.